Home Tags Dispensed

Tag: Dispensed

Jonathan Lasko, 31, holds the hand of his son Max, age 3.5, who was born with spinal muscular atrophy. A new one-time treatment was just approved for the disease, with a $2.1 million price tag.

The US just approved a $2.1 million treatment for a devastating disease. It’s the most expensive drug in the world.

The treatment, called Zolgensma, should last longer than a typical drug. It also has a much higher price tag.
Peter R. Orszag, Vice Chairman, Global Banking for Citigroup, Inc., speaks at… REUTERS 16/03/2011 08:00 USA/ Peter R. Orszag, Vice Chairman, Global Banking for Citigroup, Inc., speaks at… REUTERS 22/07/2010 08:00 OBAMA/ OMB Director Orszag waits for U.S. President Barack Obama to sign into law the… REUTERS (INS SYNDICATION) OMB Director Orszag waits for U.S. President Barack Obama to sign into law the Improper Payments Elimination and Recovery Act in Washington 22/07/2010 08:00 OBAMA/ OMB Director Orszag waits for U.S. President Barack Obama to sign into law the Improper Payments Elimination and Recovery Act in Washington

Dispensed: Medicare Advantage’s surprising success, Nurx’s rebound, and a new startup trying to upend how you get mental healthcare at wor...

Welcome to Dispensed, our weekly dispatch of healthcare, biotech, and pharma news from Business Insider.
Health startup Nurx will soon start selling tests and treatments for sexually-transmitted infections.

A $111 million health startup dubbed the ‘Uber for birth control’ is expanding into a sensitive new area: sexually-transmitted infections

There have been large and consistent increases in sexually-transmitted diseases in recent years, with almost 2.3 million cases in 2017.
The testing kit from uBiome.

I tried a test from troubled poop-testing startup uBiome that let me peek inside a ‘forgotten organ.’ Here’s what I learned.

I tried a gut-microbiome test kit from uBiome, hoping to learn more about the trillions of organisms in my digestive tract. I came away surprised.
UBiome founders Zac Apte and Jessica Richman

uBiome’s founder repeatedly presented herself as years younger than she was, in the latest sign of trouble at the embattled $600 million poop-te...

Cofounder Jessica Richman presented herself as years younger than she was, in an apparent effort to be included in articles showcasing young founders.
To prepare for its nationwide launch next week, Impossible Foods had to change the recipe for its "bleeding" veggie burgers.

Dispensed: How health insurance startups fared at the start of 2019, Impossible Foods’ big burger change, and a look at uBiome’s board

Welcome to Dispensed, our weekly dispatch of healthcare, biotech, and pharma news from Business Insider.

800 hospitals are joining forces to make their own drugs and upend the generic pharma business. They just revealed the 2 treatments they plan to make ...

Xellia Pharmaceuticals will make antibiotics for the hospitals in Civica's network, including vancomycin and daptomycin.

Online pharmacy PillPack was reportedly on track to make $299 million in revenue when Amazon acquired the company in a $750 million deal

At the time that Amazon acquired PillPack, the company was on track to make $299 million in annual revenue, according to CNBC.
Warby Parker and SmileDirectClub are inking deals with insurers.

Dispensed: Troubles at uBiome, pharma giant Merck’s plan to upend the $20 billion HIV market, and why insurers are starting to embrace brands li...

Welcome to Dispensed, our weekly dispatch of healthcare, biotech, and pharma news from Business Insider.

Denver just became the first city in the US to decriminalize magic mushrooms. Here’s what they do to your body and mind.

Mushroom's active ingredient is a drug called psilocybin, which has the potential to address conditions like anxiety and depression.